Related Experiment Videos
RNA interference in human cells is restricted to the cytoplasm
1Department of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710, USA.
RNA (New York, N.Y.)
|August 9, 2002
Summary
RNA interference (RNAi) degrades target messenger RNA (mRNA). This study shows RNAi occurs in the cytoplasm and during nuclear export, but not in the nucleus.
Area of Science:
- Molecular Biology
- Gene Regulation
- Eukaryotic Gene Expression
Background:
- RNA interference (RNAi) is a conserved eukaryotic mechanism for gene silencing.
- RNAi involves the specific degradation of target mRNA by double-stranded RNA.
- The precise subcellular location of RNAi-mediated mRNA degradation in human cells remains incompletely understood.
Purpose of the Study:
- To determine the subcellular site of RNAi-mediated mRNA degradation in human cells.
- To investigate whether RNAi affects mRNAs in the nucleus, cytoplasm, or during nuclear export.
- To elucidate the role of mRNA localization in RNAi efficacy.
Main Methods:
- Utilized the retroviral Rev/RRE system to control nuclear export of target mRNAs.
- Exposed human cells to double-stranded short interfering RNAs (siRNAs).
- Quantified target mRNA levels in nuclear and cytoplasmic fractions under different export conditions.
Main Results:
- Nuclear-localized target mRNAs were resistant to RNAi.
- Cytoplasmic target mRNAs were efficiently degraded by RNAi upon Rev-induced export.
- A significant reduction in nuclear target mRNA levels was observed during active nuclear export, suggesting degradation during this process.
Conclusions:
- RNAi-mediated mRNA degradation occurs in the cytoplasm.
- RNAi can also induce degradation of target mRNAs during their export from the nucleus.
- Nucleoplasmic mRNAs and pre-mRNAs are resistant to RNAi, highlighting the importance of mRNA localization.